GILD
Gilead Sciences, Inc.
- Selling, general and administrative, 2025
- $5.8B
- YoY, 2025
- −5.2%
- 5-year CAGR
- +2.3%
- 10-year CAGR
- +5.4%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $5.8B | −5.2% |
| 2024 | $6.1B | 0.0% |
| 2023 | $6.1B | +7.4% |
| 2022 | $5.7B | +8.1% |
| 2021 | $5.2B | +1.8% |
| 2020 | $5.2B | +17.6% |
| 2019 | $4.4B | +8.0% |
| 2018 | $4.1B | +4.6% |
| 2017 | $3.9B | +14.1% |
| 2016 | $3.4B | −0.8% |
| 2015 | $3.4B | +14.9% |
| 2014 | $3.0B | +75.6% |
| 2013 | $1.7B | +16.3% |
| 2012 | $1.5B | +17.6% |
| 2011 | $1.2B | +18.9% |
| 2010 | $1.0B | +10.3% |
| 2009 | $947M | +18.7% |
| 2008 | $797M | +13.0% |
| 2007 | $706M | — |